Latest Millennium Pharmaceuticals Stories
Results show adding LBH589 to bortezomib and dexamethasone significantly improved PFS by 37%, meeting Phase III study primary endpoint1 EAST HANOVER, N.J., June 2, 2014 /PRNewswire/ -- Novartis
LONDON, May 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
SAN DIEGO, April 7, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
ZURICH, March 18, 2014 /PRNewswire/ -- Takeda Pharmaceuticals International GmbH ("Takeda") today announced that Giles Platford has been appointed Head of Commercial Operations,
SAN DIEGO, Feb. 5, 2014 /PRNewswire/ -- Ambrx Inc. today announced the appointment of Barry Greene to its board of directors. Mr.
CAMBRIDGE, Mass., Jan.